Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Downgrades Fiskers Outlook Lowers Price Target

Elaine Mendonca by Elaine Mendonca
January 17, 2024
in Breaking News
0
Automotive Trading online
0
SHARES
5
VIEWS
Share on FacebookShare on Twitter

On January 17, 2024, Jeffrey Osborne, an analyst at TD Cowen, made a significant revision to Fisker (NYSE: FSR) by downgrading its status from Outperform to Market Perform. Additionally, the price target was adjusted from $11 to a mere $1. This alteration in viewpoint suggests a diminished level of optimism regarding Fisker’s future performance and potential.

FSR Stock Performance on January 17, 2024: Steep Decline Indicates Bearish Sentiment

FSR Stock Performance on January 17, 2024: A Steep Decline

On January 17, 2024, FSR stock experienced a significant decline in its price momentum. The stock was observed to be trading near the bottom of its 52-week range and below its 200-day simple moving average. This indicates a bearish sentiment among investors and suggests that the stock may be facing some challenges in the market.

The price of FSR shares dropped by $0.06 since the market last closed, representing a 6.18% decrease. The stock closed at $0.97.

Moreover, the stock experienced a further drop of $0.04 in pre-market trading.

Trading near the bottom of its 52-week range suggests that FSR stock has been struggling to gain positive traction in the market for some time. It also implies that the stock’s current price is relatively low compared to its recent price history.

Furthermore, trading below its 200-day simple moving average is another negative signal for FSR stock.

It is important to note that the information provided is based on the data available at the time of writing and may be subject to change. Investors should conduct their own research and analysis or consult with a financial advisor before making any investment decisions.

In conclusion, FSR stock experienced a significant decline in its price momentum on January 17, 2024. Trading near the bottom of its 52-week range and below its 200-day simple moving average, the stock’s performance suggests a bearish sentiment among investors. The $0.06 drop since the market last closed, along with the additional $0.04 decrease in pre-market trading, further emphasizes the negative momentum. Investors should closely monitor these developments and exercise caution when making investment decisions related to FSR stock.

FSR Stock Performance on January 17, 2024: Revenue Surges 222.64% YoY, Net Income Declines – SEO Optimized

FSR Stock Performance on January 17, 2024:

Total revenue has surged from $342,000 to $71.8 million, reflecting a staggering increase of 222.64% over the past year. Similarly, when compared to the previous quarter, total revenue has skyrocketed by an astounding 8,603.03%.

However, net income has declined from -$547.50 million to -$95.22 million in the third quarter of 2023, representing a decrease of 16.16% over the past year. Additionally, net income declined by 15.27% compared to the previous quarter.

Earnings per share (EPS) stood at -$1.80 over the past year, which represents an 11.8% decrease compared to the previous year. In the third quarter of 2023, the EPS dropped to -$0.28, reflecting a decline of 12.85% compared to the previous quarter.

FSR’s ability to convert sales into profits is a concern for investors. The company’s financial performance will be closely monitored in the coming months to determine if it can regain profitability.

Investors should consider various factors before making investment decisions, as stock performance is influenced by market conditions, industry trends, and company-specific developments.

Tags: FSR
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biotechnology Trading online

Veeco Instruments Inc Releases Financial Guidance and Outlook for 2023 and 2024

Automotive Stock Market Today

Factors Contributing to Teslas Stock Decline and Upcoming Earnings Report

Inflammasome Activation Linked to Brain Metastasis in TripleNegative Breast Cancer

Recommended

Super Micro Computer Stock

Super Micro Stock Surges Amid AI Infrastructure Boom

4 months ago
Adobe Stock

Adobe’s AI Ambitions Face Investor Skepticism

4 months ago
IBM Stock

Strong IBM Earnings Fail to Impress Market as Key Segment Shows Weakness

4 months ago
Inozyme Pharma Inc Stock

Inozyme Pharma Acquisition Finalized: Strategic Focus Shifts to Clinical Development

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

Great Lakes Dredge & Dock: A Cash Flow Inflection Point Approaches

Investors Await March Report for Boston Omaha’s Strategic Direction

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

Trending

Orthofix Medical Stock
Earnings

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

by Rodolfo Hanigan
February 7, 2026
0

Investor attention turns to Orthofix Medical as the company bolsters the clinical support for its biologics business...

CrossFirst Bankshares Stock

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Golden Entertainment Stock

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

February 7, 2026
Myers Industries Stock

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
OneSpan Stock

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio
  • A New Chapter for First Busey as CrossFirst Merger Finalizes
  • Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com